Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India


NexGard SPECTRA® is a soft, flavourful monthly chew that kills fleas before they can lay eggs, ticks, and mites while eliminating gastro-intestinal worms and preventing heartworm disease, lungworm and eyeworm infections. It is a comprehensive protection in a single monthly chewable, offering convenience, safety and peace of mind to pet parents.

Boehringer Ingelheim, a global leader in animal health, announced the launch of NexGard SPECTRA® (afoxolaner and milbemycin oxime) in India, following its approval by the Central Drugs Standard Control Organisation (CDSCO). NexGard SPECTRA® has demonstrated rapid action, killing fleas within four hours post-treatment, and over 99% effectiveness was observed at eight hours.

“Effective parasites control in pets is not just about treating, but also about preventing. NexGard SPECTRA® signifies a major step forward in comprehensive parasite control, providing a convenient and effective solution for veterinarians as well as pet parents. It reflects our unwavering commitment to innovation. Remember, a healthy pet means a healthy home.” said Dr. Vinod Gopal, Country Head – Animal Health, Boehringer Ingelheim India.